| HMGA2 gene is overexpressed in pituitary adenomas and thus plays a role in pituitary oncogenesis | pituitary, |
| High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. | pituitary, |
| HMGA2 is an oncogene important in the pathogenesis of human lung cancer | lung, |
| HMGA2 participates in transformation in human lung cancer. | lung, |
| HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. | pancreatic, |
| HMGA2: A pituitary tumour subtype-specific oncogene?. | pituitary, |
| Findings show that HMGA2 overexpression confers a powerful oncogenic signal in ovarian cancers through the modulation of EMT genes. | ovarian, |
| Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway. | sarcoma, |
| LSINCT5 may possibly contribute to non-small cell lung cancer tumorigenesis by stabilizing the oncogenic factor of HMGA2. | lung, |
| Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer. | prostate, |
| A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells. | None |
| Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. | None |
| The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. | None |
| DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells. | None |
| Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes. | None |
| Probing into the biological processes influenced by ESC factor and oncoprotein HMGA2 using iPSCs. | None |
| Development of peptide nucleic acid probes for detection of the HER2 oncogene. | None |